Glenmede Trust CO Na Cocrystal Pharma, Inc. Transaction History

Glenmede Trust CO Na

  • $20.6 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019
SELL
$2.65 - $4.14 $2,207 - $3,448
-833 Closed
0 $0
Q2 2018

Aug 15, 2018
BUY
$1.79 - $6.25 $1,491 - $5,206
833 New
833 $3,000

About Cocrystal Pharma, Inc.

COCP Quotes by TradingView
  • Ticker COCP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,122,420
  • Market Cap $17.6M
  • Description
  • Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...
More about COCP
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email